Asad Ikram: Headache and Visual Impairment in Idiopathic Intracranial Hypertension
Asad Ikram, Assistant Professor of Medicine at Anne Burnett Marion School of Medicine at Texas Christian University, shared a post on LinkedIn about a recent article by Gabriel Bsteh et al, published on European Journal of Neurology, adding:
“Headache and Visual Impairment in idiopathic intracranial hypertension (IIH)
The role of surgical interventions in IIH related headache vs visual impairment and what those offer: a very pragmatic look at when and in whom procedures actually help.
Across multiple tertiary centers, investigators evaluated outcomes of patients undergoing CSF shunting, venous sinus stenting, or optic nerve sheath fenestration (ONSF), with a focus on how indication for surgery (vision vs headache) influences results.
What stands out is that surgery is consistently effective for vision preservation, with most patients showing stabilization or improvement in visual function after intervention.
However, outcomes for headache control were far less predictable, with a significant proportion continuing to have persistent or recurrent symptoms despite technically successful procedures.
Complication and revision rates particularly for shunts were not negligible, reinforcing the need for careful patient selection.
From a neurovascular and stroke-adjacent perspective, this is highly relevant because we often encounter IIH in young patients presenting with headache or visual symptoms, sometimes mimicking vascular pathology and often associated with Dural Venous Sinus thrombosis needing anticoagulation.
The key takeaway is that surgical intervention should be driven primarily by visual risk rather than headache alone, and that multidisciplinary evaluation (neurology, neuro-ophthalmology, neurosurgery) is critical before committing patients to invasive therapies.”
Title: Surgical Interventions in Idiopathic Intracranial Hypertension—A Comprehensive Multi‐Center Study of Outcome and the Role of Treatment Indication
Authors: Gabriel Bsteh, Nadja Skadkær Hansen, Sina Zaic, Steffen Hamann, Johanne Juhl Korsbæk, Nik Krajnc, Stefan Macher, Laleh Dehghani Molander, Klaus Novak, Therese Wallentin Steenfos, Marianne Wegener, Berthold Pemp, Rigmor Højland Jensen, Dagmar Beier, Kaare Fugleholm, Marianne Juhler, Karl Kirchner, Martin Michl, Christoph Mitsch, Nina Müller, Petersen Bibi Gronemann, Andreas Reitner, Christoph Stapf, Christian Wöber, Karin Zebenholzer
Read the Full Article on European Journal of Neurology

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026